World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
29776
World Ranking
1349
National Ranking
113

Peter Bradding publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter Bradding sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 370 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter Bradding D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Bradding sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter Bradding is affiliated with the University of Leicester in the United Kingdom, contributing extensively to the field of Medicine with a particular focus on Pulmonary and Respiratory Medicine.

Their research covers various interconnected subfields including Physiology, Immunology, Immunology and Allergy, and Pediatrics, Perinatology and Child Health. These areas support investigations into respiratory diseases and immune responses related to asthma and other pulmonary conditions.

The main topics of their work include:

  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • IL-33, ST2, and ILC Pathways
  • Mast cells and histamine
  • Pharmaceutical studies and practices

Peter Bradding has authored and co-authored numerous scientific papers in reputable journals. Selected recent publications include:

  • "Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial," 2020, The Lancet Respiratory Medicine
  • "ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19," 2020, Journal of Allergy and Clinical Immunology
  • "Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes," 2022, American Journal of Respiratory and Critical Care Medicine
  • "Airway hyperresponsiveness in asthma: The role of the epithelium," 2024, Journal of Allergy and Clinical Immunology
  • "Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma," 2021, American Journal of Respiratory and Critical Care Medicine

Frequent co-authors in their research collaborations include Liam G. Heaney, Rekha Chaudhuri, Joseph R. Arron, Adel Mansur, and Ian Pavord. These collaborations have been significant in advancing studies around asthma and respiratory medicine.

The publication venues where Peter Bradding frequently publishes are:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Allergy
  • American Journal of Respiratory and Critical Care Medicine
  • Journal of Allergy and Clinical Immunology
  • European Respiratory Journal

Best Publications

  • Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

    Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta

  • Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

    Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon

  • Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

    Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate

  • Evidence of a role of tumor necrosis factor alpha in refractory asthma.

    Mike A. Berry;Beverley Hargadon;Maria Shelley;Debbie Parker

  • Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.

    P Bradding;J A Roberts;K M Britten;S Montefort

  • The role of the mast cell in the pathophysiology of asthma.

    Peter Bradding;Andrew F. Walls;Stephen T. Holgate

  • Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

    Guiquan Jia;Richard W. Erickson;David F. Choy;Sofia Mosesova

  • Interleukin 4 is localized to and released by human mast cells

    P Bradding;I H Feather;P H Howarth;R Mueller

  • Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

    Mike Berry;Angela Morgan;Dominick E Shaw;Deborah Parker

  • TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma

    David F. Choy;Kevin M. Hart;Lee A. Borthwick;Aarti Shikotra

  • Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease

    C E Brightling;S McKenna;B Hargadon;S Birring

  • Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung Cancer

    Tomas J. Welsh;Ruth H. Green;Donna Richardson;David A. Waller

  • Heterogeneity of human mast cells based on cytokine content.

    P Bradding;Y Okayama;P H Howarth;M K Church

  • Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma

    Aarti Shikotra;David F. Choy;Chandra M. Ohri;Emma Doran

  • The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle

    Christopher E. Brightling;Alaina J. Ammit;Davinder Kaur;Judith L. Black

  • Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival.

    C M Ohri;A Shikotra;R H Green;D A Waller

  • Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy

    Stephen T. Holgate;Peter Bradding;Anthony P. Sampson

  • Comparison of airway immunopathology of eosinophilic bronchitis and asthma

    C E Brightling;F A Symon;S S Birring;P Bradding

  • Increased sputum and bronchial biopsy IL-13 expression in severe asthma

    Shironjit K. Saha;Mike A. Berry;Deborah Parker;Salman Siddiqui

  • The relationship between clinical outcomes and medication adherence in difficult-to-control asthma

    Anna C Murphy;Amandine Proeschal;Christopher E Brightling;Andrew J Wardlaw

  • IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma

    Abbie Fairs;Joshua Agbetile;Beverley Hargadon;Michelle Bourne

Frequent Co-Authors

Christopher E. Brightling
Christopher E. Brightling University of Leicester
Andrew J. Wardlaw
Andrew J. Wardlaw University of Leicester
Ian D. Pavord
Ian D. Pavord University of Oxford
Yassine Amrani
Yassine Amrani University of Leicester
Liam G. Heaney
Liam G. Heaney Queen's University Belfast
Peter H. Howarth
Peter H. Howarth University of Southampton
Carol Feghali-Bostwick
Carol Feghali-Bostwick Medical University of South Carolina
Heike Wulff
Heike Wulff University of California, Davis
Stephen T. Holgate
Stephen T. Holgate University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees online is a popular pathway. Programs like the best pmhnp programs online offer excellent clinical placement rates, ensuring practical experience alongside theoretical knowledge.

Cost is a critical consideration for many students. Fortunately, there are affordable options available, such as the cheapest psych np programs online, which provide quality education without the heavy financial burden.

Career outcomes for nurse practitioners with a Doctor of Nursing Practice (DNP) degree are promising, with salary variations by location. Understanding the dnp salary by state can help professionals make informed decisions about job prospects and relocation.

For those looking to specialize further, transitioning to roles like an Acute Care Nurse Practitioner requires additional certification. Guidance on how to achieve this goal is useful, as detailed in resources about acute care nurse practitioner certification.

Best Scientists Citing Peter Bradding

Trending Scientists

Recently Published Articles